Search Results 511-520 of 17449 for alopecia

  1. Mayo Clinic

    Share · Tweet . IMG-20420243. Home; Giving to Mayo Clinic-Ways to Give-Employee and Retiree Giving. 5X Challenge is here!

  2. Lice - Symptoms and causes - Mayo Clinic

    Lice are tiny, wingless insects that feed on human blood. Lice spread from person to person through close contact and by sharing clothes and other items.

  3. Brightcove-Stereotactic radiosurgery-the mayo clinic approach

    Bruce Pollock, M.D., Neurosurgery, Mayo Clinic: Stereotactic radiosurgery is an outpatient-based radiation procedure. You're going to walk in, have this done, ...

  4. Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL - Mayo Clinic

    ... alopecia) due to therapy administered prior to the initiation of study drug dosing. Nursing or pregnant. Known allergy or hypersensitivity to any of the ...

  5. Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma - Mayo Clinic

    Any unresolved toxicity NCI CTCAE Grade ≥ 2 from previous anticancer therapy; with the exception of vitiligo and alopecia. Participating Mayo Clinic ...

  6. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  7. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

    ... alopecia (any grade permissible). No more than one prior chemotherapy regimen for advanced or metastatic breast cancer is allowed; prior chemotherapy for ...

  8. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

    Recovery to Grade ≤ 1 for any non-laboratory toxicity resulting from previous anticancer therapy prior to first dose of ALPN-202 (except alopecia, hearing ...

  9. A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

    ... alopecia or peripheral neuropathy. Have discontinued all previous therapies for cancer (including chemotherapy, radiotherapy, immunotherapy, and endocrine ...

  10. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

    The following are exceptions to this criterion: subjects with vitiligo or alopecia; subjects with hypothyroidism (e.g., following Hashimoto syndrome) stable ...